| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
Correspondence to: Dr I A Campbell
Received 10 May 1999; Returned to author 23 July 1999; Revised version received 14 October 1999; Accepted for publication 22 November 1999
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
Guidelines have been produced for tuberculosis by the British Thoracic Society (BTS),1 2 the American Thoracic Society (ATS),3 the International Union Against Tuberculosis and Lung Disease,4 and the World Health Organisation.5 These, however, deal mainly with Mycobacterium tuberculosis complex infections (M tuberculosis, M africanum, and M bovis). With the exception of the ATS guidelines on non-tuberculous mycobacteria,3 these do not address the opportunist mycobacteria (also called atypical mycobacteria, mycobacteria other than tuberculosis (MOTT), non-tuberculous mycobacteria (NTM), or environmental mycobacteria).
The number of isolates of such opportunist mycobacteria has been
increasing,6 both in HIV negative and HIV positive
individuals. Because of the growing numbers of patients with disease
due to infection by these mycobacteria, the wide range of species, the difficulties in both diagnosis and management, and in response to
increasing requests for advice on management, the BTS Joint Tuberculosis Committee has reviewed the evidence on management of
This article has been cited by other articles:
|
|
 |
|
  M. Santin, J. Dorca, F. Alcaide, L. Gonzalez, S. Casas, M. Lopez, and M. R. Guerra Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease Eur. Respir. J., January 1, 2009; 33(1): 148 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A Jenkins, I A Campbell, J Banks, C M Gelder, R J Prescott, and A P Smith Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy Thorax, July 1, 2008; 63(7): 627 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kitada, K. Kobayashi, S. Ichiyama, S. Takakura, M. Sakatani, K. Suzuki, T. Takashima, T. Nagai, I. Sakurabayashi, M. Ito, et al. Serodiagnosis of Mycobacterium avium-Complex Pulmonary Disease Using an Enzyme Immunoassay Kit Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 793 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. McGrath and N. Qureshi Mycobacterium chelonei: friend or foe? Eur. Respir. J., August 1, 2007; 30(2): 397 - 397. [Full Text] [PDF]
|
|
|
|
|
|
T. K Marras, P. Chedore, A. M Ying, and F. Jamieson Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003 Thorax, August 1, 2007; 62(8): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Williams, C. L. Ling, C. Jenkins, S. H. Gillespie, and T. D. McHugh A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory J. Med. Microbiol., May 1, 2007; 56(5): 598 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Griffith, T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 367 - 416. [Full Text] [PDF]
|
|
|
|
|
|
N. Schonfeld The mycobacterial mystery Eur. Respir. J., December 1, 2006; 28(6): 1076 - 1078. [Full Text] [PDF]
|
|
|
|
|
|
M. Dailloux, M. L. Abalain, C. Laurain, L. Lebrun, C. Loos-Ayav, A. Lozniewski, J. Maugein, and the French Mycobacteria Study Group Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients Eur. Respir. J., December 1, 2006; 28(6): 1211 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Fowler, J. French, N. J. Screaton, J. Foweraker, A. Condliffe, C. S. Haworth, A. R. Exley, and D. Bilton Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Eur. Respir. J., December 1, 2006; 28(6): 1204 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kunst, M. Wickremasinghe, A. Wells, and R. Wilson Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Eur. Respir. J., August 1, 2006; 28(2): 352 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Field and R. L. Cowie Lung Disease Due to the More Common Nontuberculous Mycobacteria Chest, June 1, 2006; 129(6): 1653 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Koh, O. J. Kwon, K. Jeon, T. S. Kim, K. S. Lee, Y. K. Park, and G. H. Bai Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest, February 1, 2006; 129(2): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Wickremasinghe, L J Ozerovitch, G Davies, T Wodehouse, M V Chadwick, S Abdallah, P Shah, and R Wilson Non-tuberculous mycobacteria in patients with bronchiectasis Thorax, December 1, 2005; 60(12): 1045 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Gillespie, S. Basu, A. L. Dickens, D. M. O'Sullivan, and T. D. McHugh Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates J. Antimicrob. Chemother., August 1, 2005; 56(2): 344 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Maliwan and J R Zvetina Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience Postgrad. Med. J., August 1, 2005; 81(958): 530 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Benton, S. Musaad, R. Vaughan, and L. McLean Recurrent multifocal Mycobacterium kansasii infection in an immunosuppressed patient with myelodysplasia and relapsing polychondritis Rheumatology, November 1, 2004; 43(11): 1453 - 1454. [Full Text] [PDF]
|
|
|
|
|
|
E. J. Olafsson, C. C. Naum, G. A. Sarosi, and J. G. Mastronarde Bilateral Pleural Effusions and Right Pneumothorax in a 25-Year-Old Man Chest, September 1, 2004; 126(3): 986 - 992. [Full Text] [PDF]
|
|
|
|
|
|
M.T. Henry, L. Inamdar, D. O'Riordain, M. Schweiger, and J.P. Watson Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response Eur. Respir. J., May 1, 2004; 23(5): 741 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Primm, C. A. Lucero, and J. O. Falkinham III Health Impacts of Environmental Mycobacteria Clin. Microbiol. Rev., January 1, 2004; 17(1): 98 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Miles, T K Walters, and C D Shee Periprosthetic tuberculous breast infection J R Soc Med, November 1, 2003; 96(11): 556 - 557. [Full Text] [PDF]
|
|
|
|
|
|
J Salazar-Schicchi, S A Nachman, C Bachmeyer, S Stelianides, and L Blum Mycobacterium xenopi Thorax, July 1, 2002; 57(7): 658 - 658. [Full Text] [PDF]
|
|
|
|
|
|
M.-M. Gordon, H. E. Wilson, F. R. Duthie, B. Jones, and M. Field When typical is atypical: mycobacterial infection mimicking cutaneous vasculitis Rheumatology, June 1, 2002; 41(6): 685 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P ORMEROD A step forward in the evidence-based treatment of opportunist mycobacteria Thorax, March 1, 2001; 56(3): 163 - 163. [Full Text]
|
|
|
|
|
|
Research Committee of the British Thoracic Society First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol Thorax, March 1, 2001; 56(3): 167 - 172. [Abstract] [Full Text]
|
|
|
|
|
|
G. PORTER-JONES "Opportunist" mycobacterial infection Thorax, January 1, 2001; 56(1): 84a - 84. [Full Text]
|
|
|
|
|
|
P D O DAVIES, J M GRANGE;, I A CAMPBELL, and L P ORMEROD Antibiotic prescribing in the community. Thorax, August 1, 2000; 55(8): 722 - 722. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
